Know Cancer

or
forgot password


N/A
18 Years
N/A
Not Enrolling
Both
Common Melanocytic Nevi

Thank you

Trial Information


Inclusion Criteria:



- Patients visiting the Sheba Medical Center pigmented lesion clinic for skin
examination

- Patients having at least three banal-appearing nevi, one on the upper back, one on
the lower back and one on the lower extremity (excluding foot), which are amenable
for RCM examination.

Exclusion Criteria:

- Patients who are unwilling or medically unable to lie down for 30 minutes.

- Pregnant women

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Inter-rater agreement on assignment of nevi to RCM patterns (baseline and follow-up images).

Outcome Time Frame:

3 YEARS

Safety Issue:

No

Principal Investigator

ALON SCOPE, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Sheba Medical Center

Authority:

Israel: Israeli Health Ministry Pharmaceutical Administration

Study ID:

SHEBA-10-8015-AS-CTIL

NCT ID:

NCT01194947

Start Date:

September 2010

Completion Date:

September 2013

Related Keywords:

  • Common Melanocytic Nevi
  • banal-appearing nevi
  • NEVUS
  • Nevus
  • Nevus, Pigmented
  • Nevus, Epithelioid and Spindle Cell

Name

Location